The U.S. market for legal cannabis is booming, bringing in $2.7 billion last year, according to The ArcView Group. That figure is a 74% jump from 2013.  

AXIM Biotechnologies, a biotech company specializing in cannabinoid research and commercial hemp product development, hopes to cash in on the craze in a very unique and creative way. The New York and Netherlands-based firm manufactures several patent-pending products using cannabis for better health.

“We use unique cannabinoids, which are not psychotropic,” said George Anastassov, AXIM Biotechnologies CEO.  “When people talk about marijuana, they usually think about the psychotropic effects from THC. We utilize certain alkaloids that come from the cannabis plant that have beneficial effects to the human body.”

This week, AXIM unveiled a cannabinoid-based oral care line of toothpaste, mouthwash and dentifrice using its distinctive technique. It’s the first-to-market with products containing CBG, which Anastassov describes as the "pioneer cannabinoid," that came...